mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |